Inventiva S.A. American Depository Shares (IVA)
NASDAQ
$3.34+$0.0800 (+2.45%) on the dayAs of the close; data may be delayed.
IVA price, last 12 months
Key stats
- Previous close
- $3.26
- Open
- $3.24
- Day range
- $3.15 – $3.43
- 52-week range
- $3.11 – $7.98
- Volume
- 3M
- Avg volume (20 days)
- 1.6M
- Market cap
- $796.1M
Performance
1W−11.6%
1M−30.7%
3M−2.1%
6M−45.2%
YTD−28.2%
1Y−39.5%
vs S&P 500, 1Y−56.3 pts
Technicals and fundamentals
About Inventiva S.A. American Depository Shares
Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging the expertise, the company is also advancing lanifibranor for the treatment of MASH and has a pipeline of earlier-stage therapeutic programs in oncology. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France.
- Listed on
- NASDAQ
- Market cap
- $796.1M